Thus, IL-33 had a protective effect against obesity, insulin resistance and diabetes in animal models [62] due to the reduction of resistin expression, accumulation of Th2 cells and IL-5, IL-13 and the suppression of T effectors cells by IL-10 releasing [63]. The gene discussed is RETN; the disease is obesity disorder.